1. Short Half-Life and Frequent Injections
Testosterone propionate has a short half-life of approximately 2–3 days. This means that it is cleared from the body quickly, requiring frequent injections (usually every 2–3 days) to maintain stable blood levels.
Compared to other testosterone esters like testosterone enanthate or testosterone cypionate, which have longer half-lives and require less frequent injections (every 1–2 weeks), the need for more frequent administration with testosterone propionate was seen as a major inconvenience for patients.
The frequent injections led to patient non-compliance, as many people preferred less frequent dosing for ease of use and convenience.
2. Pain and Discomfort
Testosterone propionate is known to cause injection site pain and irritation more than longer-acting testosterone esters. This discomfort, which can include redness, swelling, and pain, contributed to the reduced popularity of propionate in favor of other testosterone formulations that were perceived as more comfortable.
The pain from frequent injections often led patients to seek alternatives that were less painful and easier to administer.
3. Availability of Longer-Acting Formulations
With the development and approval of testosterone enanthate and testosterone cypionate, which have longer half-lives and require fewer injections, testosterone propionate became less favored in clinical practice.
These longer-acting forms offered similar benefits for testosterone replacement therapy but with more convenient dosing schedules and fewer injection-related side effects. As a result, testosterone propionate became less commonly prescribed in favor of these alternatives.
4. Limited Market and Lower Demand
As testosterone enanthate and testosterone cypionate became more widely available and widely used in medical practice, the demand for testosterone propionate declined.
The market for testosterone propionate became more niche, and with the emergence of more modern and efficient testosterone products, pharmaceutical companies decided to discontinue production of testosterone propionate in favor of formulations that better met patient needs.
5. Regulatory and Pharmaceutical Considerations
Over time, pharmaceutical companies may have found it more profitable to focus on producing and marketing testosterone esters with longer shelf lives and less frequent dosing schedules.
Testosterone cypionate and testosterone enanthate gained more attention due to their stability, ease of use, and patient convenience, leading to reduced emphasis on testosterone propionate in the pharmaceutical market.
6. Transition to Other Forms of Testosterone
There has also been a growing trend toward alternative forms of testosterone administration, such as testosterone patches, gels, and pellets, which offer even more convenient options for hormone replacement therapy.
These newer forms of testosterone delivery continue to replace injectable options like testosterone propionate, which further decreased its use.






